Kernel density estimates to diagnose sepsis in critical care patients by Parente, J.D. et al.

Kernel density estimates to diagnose 
sepsis in critical care patients
Jacquelyn Dawn Parente,
Dominic Lee, Jessica Lin, J. Geoffrey Chase, 
Geoffrey M. Shaw
















< 32 mm Hg
White blood cell count
< 4 x 109/L





We aim to diagnose ‘severe’ sepsis 





Severe sepsis is common, often kills, and 






Sepsis is the 10th leading cause of 
death in the USA.
6% of all deaths in the USA are
sepsis-related (1999 to 2005).
Standard sepsis diagnostics are slow, 























Treat confirmed sepsis within 6h.
Blood culture (24-48h)
51% of sepsis are culture-identified
PCT biomarker (0.5-2.5h)
42-97% of sepsis diagnosed







Insulin sensitivity may be a useful sepsis 
biomarker.
Glucose control decreased sepsis incidence.
Insulin sensitivity 





























Our biomarker includes hourly insulin 
sensitivity and bedside measurements.
36 patients with sepsis









Kernel density estimates provide joint 
probability density profiles for data 
hours and classification.
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of no sepsis diagnosed
Our biomarker identifies the majority of 








































Our biomarker classification model area 
under the ROC curve (AUC) shows high 
accuracy.
Our biomarker is more accurate than 




Sepsis 51% 42% - 97% 70% - 94%































Our hourly biomarker may be faster 
than PCT.














Treat confirmed sepsis within 6h.
We confirmed 70%-94% of sepsis
AND 74% -94% of no sepsis in 1h.
Our sepsis biomarker diagnoses severe 
sepsis more quickly and accurately than 
existing diagnostic methods.
May reduce sepsis mortality, costs, 
and antibiotic resistance.
May improve quality of care.
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PCT vs Biomarker
Ongoing work
Questions?
